Back to AZN Stock Lookup

AstraZeneca (AZN) –

Sep 4, 2015 08:00 AM AstraZeneca to Update on Leading Lung Cancer Portfolio at WCLC 2015
Sep 4, 2015 07:01 AM Form 6-K ASTRAZENECA PLC For: Sep 04
Sep 3, 2015 05:49 PM US FDA Approves Expanded Indication For BRILINTA To Include Long-Term Use In Patients With A History Of Heart Attack
Sep 2, 2015 07:26 AM AstraZeneca (AZN) Enters FluMist Quadrivalent Development, Commercialization Agreement with Daiichi Sankyo
Sep 2, 2015 07:24 AM AstraZeneca (AZN) Affirms Positive Top-Line Results from RECAPTURE 1, 2
Sep 2, 2015 07:15 AM Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)
Sep 1, 2015 08:44 AM Nektar Therapeutics (NKTR) Announce Receipt of $40M Milestone Payment from AstraZeneca
Sep 1, 2015 08:04 AM Form 6-K ASTRAZENECA PLC For: Jul 09
Sep 1, 2015 06:17 AM AstraZeneca (AZN) Enters Brodalumab Licensing Agreement with Valeant (VRX)
Sep 1, 2015 06:12 AM Form 6-K ASTRAZENECA PLC For: Sep 01
Aug 28, 2015 12:48 PM Form 6-K ASTRAZENECA PLC For: Aug 28
Aug 28, 2015 12:36 PM FDA Issues Warning on DPP-4 Inhibitors in T2D (MRK) (LLY)
Aug 24, 2015 05:18 PM Market Wrap: Markets Riled on China Worries; Apple's Cook Calms Investors; Southern Co. Bets on Nat Gas
Aug 24, 2015 08:15 AM Roth Capital Positive on Peregrine Pharma (PPHM) Amid New Immunotherapy Collaboration (AZN)
Aug 24, 2015 06:30 AM Peregrine Pharma (PPHM) Enters Cancer Immunotherapy Collaboration with AstraZeneca (AZN)
Aug 24, 2015 06:12 AM Form 6-K ASTRAZENECA PLC For: Aug 24
Aug 24, 2015 02:05 AM AstraZeneca and Peregrine Pharmaceuticals to Collaborate on Immuno-Oncology Combination Clinical Trial
Aug 20, 2015 09:05 AM Advaxis (ADXS), MedImmune (AZN) Begin ADXS-HPV Phase 1/2 Enrollment
Aug 10, 2015 05:41 PM Market Wrap: Buffett Lands 'Whale' of A Deal; Google Announces Major Restructuring; Twitter Gains on Insider Trades
Aug 10, 2015 05:09 PM Diplomat Pharmacy (DPLO) Will Begin Offering IRESSA (AZN)
Aug 10, 2015 09:33 AM Pre-Open Stock Movers 08/10: (AQXP) (VLTC) (INO) (PCP) Higher; (SYN) (JD) (FCX) Lower (more...)
Aug 10, 2015 06:08 AM AstraZeneca's (AZN) MedImmune to Acquire Inovio Pharma's (INO) NO-3112 Immunotherapy Rights
Aug 3, 2015 12:55 PM Form 6-K ASTRAZENECA PLC For: Aug 03
Aug 3, 2015 06:18 AM Isis Pharma (ISIS), AstraZeneca (AZN) Enter Antisense Therapy Development Collaboration
Jul 30, 2015 11:03 AM Form 6-K ASTRAZENECA PLC For: Jul 30
Jul 30, 2015 07:13 AM Charles River Laboratorie (CRL) Misses Q2 EPS by 1c; Extends Agreement with AstraZeneca (AZN)
Jul 30, 2015 07:01 AM Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement
Jul 29, 2015 06:43 AM Form 6-K ASTRAZENECA PLC For: Jul 29
Jul 27, 2015 09:58 AM Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)
Jul 27, 2015 07:30 AM Form 6-K ASTRAZENECA PLC For: Jul 27
Jul 27, 2015 07:11 AM Form 6-K ASTRAZENECA PLC For: Jul 27
Jul 27, 2015 06:45 AM Genzyme (SNY) to Acquire AstraZeneca's (AZN) Caprelsa
Jul 22, 2015 09:30 AM Pre-Open Stock Movers 07/22: (ISRG) (THOR) (EYES) Higher; (XOMA) (ILMN) (AAPL) Lower (more...)
Jul 22, 2015 06:46 AM Array BioPharma (ARRY) Declines; AstraZeneca (AZN) Says Phase 3 SUMIT Study of Selumetinib in Combination with Dacarbazine Misses Primary Endpoint
Jul 17, 2015 09:13 AM Form 6-K ASTRAZENECA PLC For: Jul 17
Jul 17, 2015 07:10 AM Form 6-K ASTRAZENECA PLC For: Jul 17
Jul 15, 2015 05:00 PM InnerWorkings (INWK) Enters Seven-Year Marketing Agreement with AstraZeneca (AZN)
Jul 14, 2015 06:28 AM Form 6-K ASTRAZENECA PLC For: Jul 14
Jul 14, 2015 06:00 AM Ardelyx to Provide Updates on Research and Development Programs at Today's Inaugural R&D Day in New York City
Jul 13, 2015 07:27 PM CORRECTING and REPLACING IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
Jul 13, 2015 07:27 PM CORRECTING and REPLACING IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
Jul 13, 2015 07:27 PM IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
Jul 13, 2015 03:47 PM Qiagen (QGEN) Announces Receipt of FDA PMA for Therascreen EGFR Test for Use with IRESSA in NSCLC
Jul 13, 2015 01:34 PM FDA Approves AstraZeneca's (AZN) Iressa for First-line Treatment of Patients with Type of Metastatic Lung Cancer (QGEN)
Jul 9, 2015 07:15 AM Form 6-K ASTRAZENECA PLC For: Jul 09
Jul 8, 2015 08:03 AM AstraZeneca (AZN), Ironwood (IRWD) Announce All Primary, Secondary Endpoints Met in Linaclotide Phase 3
Jul 8, 2015 08:00 AM AstraZeneca Celebrates More Than 35 Years of Ongoing Patient Support Through Its Patient Assistance Programs
Jul 2, 2015 10:54 AM Notable Analyst Rating Changes 7/2: (T) (KOS) (KIM) Upgraded; (GNRC) (BTU) (RF) Downgraded
Jul 2, 2015 08:12 AM Berenberg Upgrades AstraZeneca (AZN) to Buy
Jul 1, 2015 06:40 AM Form 6-K ASTRAZENECA PLC For: Jul 01

Back to AZN Stock Lookup